NCT06195306 2026-04-13
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
10 trialsNCT03175666 2025-02-21
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT04268134 2024-02-29
ALTA
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01821833 2022-10-05
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
New Mexico Cancer Research Alliance
Phase NA Completed
NCT02996240 2021-03-17
Breast, Omega 3 Free Fatty Acid, Ph 0
The University of Texas Health Science Center at San Antonio
Phase NA Completed
NCT01823991 2020-07-14
COGNUTRIN in Breast Cancer Survivors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT01784042 2017-05-09
Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT01252290 2016-12-16
Breast Cancer Risk Biomarkers in Postmenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT01252277 2016-07-21
Breast Cancer Risk Biomarkers in Premenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT00930527 2014-07-23
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Columbia University
Phase 2 Terminated